Published November, 2014
By Toby Lawrence and Thorsten Hagemann
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

The subject of Tumour-Associated Macrophages is of interest in the cancer research community, and this book promises to be among the first to discuss a definitive theory on the role of macrophage in tumor development.

---

Published November, 2014
By Beverly A. Teicher
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

The past 6 years since the first edition of this book have seen great progress in the development of genetically engineered mouse (GEM) models of cancer.

---

Published November, 2014
By Roy Zent and Ambra Pozzi
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

Cancer was thought to originate from alterations in intercellular signaling that resulted in the transformation of cells, their uncontrolled proliferation and metastasis. Cells adhere and receive signals from various extracellular matrices via transmembrane receptors, the best known of which are the heterodimeric glycoproteins, integrins.

---

Published November, 2014
By Abdel-Majid Khatib
Publisher: Springer
Rating:
Availability: Available

Convertases are widely expressed activating enzymes involved in various physiological and pathological processes. Each chapter discusses the importance of the convertases in the activation of various cancer-related molecules including growth factors, adhesion molecules and proteases.

---

Published November, 2014
By H.-J. Biersack and F Grunwald
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

- Includes all current diagnostic techniques including FDG-PET and MRI - Second Edition is completely revised to include the latest diagnostic and theraputic concepts - Special section is devoted to medullary thyroid cancer

---

Published November, 2014
By Charisse Litchman
Publisher: Springer
Rating:
Availability: Available

Desmoid Tumors (DT), also called Aggressive Fibromatoses, are a rare fibroblastic proliferative disease, with an incidence of 2 to 4 new cases per million people per year. The role of advocacy groups in supporting research and in promoting awareness of rare diseases such as DT will be outlined.

---

Published November, 2014
By Eugene Butcher, B. Weiss, P. Bringmann, E. Butcher, G. Parry and Peter Bringmann
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Ernst Schering Foundation Symposium Proceedings
Rating:
Availability: Available

This volume features contributions from participants of an ESRF Workshop on "Systems Biology" held in Berkeley, USA, in November 2005. Recent successes and challenges of applying systems level measurements to the different steps of drug discovery and development in the pharmaceutical industry are summarized.

---

Published November, 2014
By Bernhard Haendler, D. Mumberg and Otmar D Wiestler
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Ernst Schering Foundation Symposium Proceedings
Rating:
Availability: Available

Cancer stem cells have originally been identified in leukemia and later in several solid tumor types. Current treatments might largely spare cancer stem cells. This book looks at recent developments in the field of cancer stem cells and the possible impact for the identification of novel treatment paradigms for cancer.

---

Published November, 2014
By Gabriel D. Dakubo
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

In spite of the enormous complexity of the nuclear genome, which we now fully appreciate after completion of the human genome project, the efforts of cancer researchers are commendable in terms of the tremendous gains made in unraveling the numerous genetic changes in cancer.

---

Published November, 2014
By Gary J. Kelloff, Ernest T. Hawk and Caroline C. Sigman
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

Despite significant advances in cancer treatment and measures of neoplastic progression, drug effect (or early detection, overall cancer incidence has increased, pharmacodynamic markers), and markers that measure cancer-associated morbidity is considerable, and overall prognosis as well as predict responses to specific therapy.

---